Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management


Circulating tumoral DNA (ctDNA), commonly named "liquid biopsy", has emerged as a new promising noninvasive tool to detect biomarker in several cancers including lung cancer. Applications involving molecular analysis of ctDNA in lung cancer have increased and encompass diagnosis, response to treatment, acquired resistance and prognosis prediction, while… (More)
DOI: 10.3390/ijms18020264

4 Figures and Tables


  • Presentations referencing similar topics